Martin Møller
Chairman at SCANDION ONCOLOGY A/S
Network origin in Martin Møller first degree
Entity | Entity type | Industry | |
---|---|---|---|
24
| Public Company | Pharmaceuticals: Major | 24 |
Public Company | Pharmaceuticals: Major | 18 | |
Edvince AB
Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden.
4
| Holding Company | Biotechnology | 4 |
Rehaler ApS
Rehaler ApS Medical SpecialtiesHealth Technology Rehaler ApS develops medical devices for the treatment of migraine.
2
| Private Company | Medical Specialties | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Martin Møller via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
University of Lund | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
University of Copenhagen | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree | |
WNTRESEARCH AB | Pharmaceuticals: Other | Director/Board Member Director of Finance/CFO Chief Executive Officer General Counsel | |
Technical University of Denmark | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
Dako Denmark ApS
Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Medical Specialties | Chief Executive Officer Sales & Marketing | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
University of Southern Denmark | College/University | Graduate Degree Corporate Officer/Principal | |
QIAGEN N.V. | Medical Specialties | General Counsel Compliance Officer | |
Immunovia, Inc. | Chief Tech/Sci/R&D Officer Chief Executive Officer | ||
Euro-Diagnostica AB
Euro-Diagnostica AB Pharmaceuticals: MajorHealth Technology Euro-Diagnostica AB provides autoimmunity testing and diagnostic solutions. It facilitates the development of safe and efficient drugs and optimal treatment of patients by providing cutting edge assays. The firm also provides clinical labs and physicians with tools to aid in diagnosis, prognosis, monitoring, and treatment of inflammatory and related diseases. The company was founded in 1992 and is headquartered in Malmo, Sweden. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
Copenhagen Business School | College/University | Graduate Degree Graduate Degree | |
University of London | College/University | Graduate Degree Graduate Degree | |
H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
ALLIGATOR BIOSCIENCE AB | Biotechnology | Founder Chairman | |
Atlas Therapeutics AB
Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Pharmaceuticals: Major | Director/Board Member Chairman | |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Qiagen AG
Qiagen AG Medical SpecialtiesHealth Technology Qiagen AG manufactures biological products for purification, transfection, and amplification of nucleic acid and proteins. The company was founded on September 15, 1994 and is headquartered in Basel, Switzerland. | Medical Specialties | Chairman | |
Peak-Service GmbH | Chief Executive Officer | ||
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
QIAGEN Euro Finance (Luxembourg) SA | Finance/Rental/Leasing | Director/Board Member | |
Qiagen Finance (Luxembourg) SA | Finance/Rental/Leasing | Director/Board Member | |
Peak-Services France SARL | Chairman | ||
PEAK-Service Ltd. | Director/Board Member | ||
QIAGEN Instruments AG
QIAGEN Instruments AG Medical SpecialtiesHealth Technology QIAGEN Instruments AG engages in the development, production, and distribution of analytical instruments and devices. It also acquires participating interests in firms, as well as acquires and utilizes patents, licenses, and other rights. The company was founded on February 28, 1990 and is headquartered in Hombrechtikon, Switzerland. | Medical Specialties | Chief Executive Officer | |
QIAGEN MARSEILLE | Miscellaneous Commercial Services | Director/Board Member | |
S:t Eriks Ögonsjukhus AB
S:t Eriks Ögonsjukhus AB Hospital/Nursing ManagementHealth Services S:t Eriks Ögonsjukhus AB operates eye hospitals. It specializes in corneal transplant; medical and surgical treatments of retina; oculoplastic surgery, ophthalmic oncology and pathology services; and medical contact lens service for infants and children. The company is headquartered in Stockholm, Sweden. | Hospital/Nursing Management | Director/Board Member | |
VINNOVA AB
VINNOVA AB Financial ConglomeratesFinance VINNOVA AB provides funding services and financial assistance. It promotes collaborations between companies, universities, research institutes and the public sector. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Financial Conglomerates | Corporate Officer/Principal | |
Malmö Högskola | College/University | Undergraduate Degree | |
European Organisation for Research & Treatment of Cancer | Director/Board Member | ||
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor | |
InnovationsFonden
InnovationsFonden Investment ManagersFinance InnovationsFonden provides investment services. It invests in entrepreneurs, researchers, and businesses. The company was founded on January 4, 2005 and is headquartered in Copenhagen, Denmark. | Investment Managers | Chief Executive Officer | |
Qiagen US Finance Holding (Luxembourg) SARL | Director/Board Member | ||
University of Hamburg | College/University | Graduate Degree | |
Glycom A/S
Glycom A/S BiotechnologyHealth Technology Glycom A/S engages in the development, synthesis, and commercialization of human milk oligosaccharides. It develops chemical and enzymatic technologies for synthesis of human milk oligosaccharide powders. The company was founded by Gyuala Dekany, Mark von Itzstein, Joachim Erich Thiem, Arnold Stutz, and Inge Lundt on March 22, 2005 and is headquartered in Horsholm, Denmark. | Biotechnology | Founder | |
Holm & Gross Holding AB
Holm & Gross Holding AB Financial ConglomeratesFinance Holm & Gross Holding AB is a Swedish company that owns and manages shares. The private company is based in Helsingborg, Sweden. | Financial Conglomerates | Corporate Officer/Principal | |
Qlife ApS | Chairman | ||
QLIFE HOLDING AB | Medical Specialties | Chairman | |
HOODIN AB | Packaged Software | Director/Board Member | |
Qvickbron Industriutveckling AB | Director/Board Member | ||
Mlh Management AB
Mlh Management AB Miscellaneous Commercial ServicesCommercial Services Mlh Management AB provides corporate consulting services. The private company is based in Helsingborg, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
Lennart Holm Development AB | Corporate Officer/Principal | ||
Holm Investment AB
Holm Investment AB Investment Banks/BrokersFinance Holm Investment AB provides securities management and trading services. The private company is based in Helsingborg, Sweden. | Investment Banks/Brokers | Corporate Officer/Principal | |
Axolot Solutions AB | Corporate Officer/Principal | ||
Sino Danish Breast Cancer Research Centre | Director/Board Member | ||
Kellogg School of Management | College/University | Masters Business Admin | |
Vigmed Holding AB
Vigmed Holding AB Medical DistributorsDistribution Services Vigmed Holding AB engages in the development, manufacturing distribution, and sale of protected needle products. Its products include a fully automatic safety intravenous catheter called Vigmed CLiP Ven, a winged safety intravenous catheter called Vigmed CLip Neo, and Vigmed Swing, a first safety cover for hypodermic needles. The company was founded by Per Anders Knutsson, Hans Mikael Karlsson, and Rikard Anders Roos in 2009 and is headquartered in Helsingborg, Sweden. | Medical Distributors | Director of Finance/CFO |
Statistics
International
Sweden | 19 |
Denmark | 16 |
United States | 4 |
Luxembourg | 4 |
Netherlands | 3 |
Sectoral
Health Technology | 18 |
Consumer Services | 10 |
Finance | 8 |
Commercial Services | 3 |
Miscellaneous | 2 |
Operational
Director/Board Member | 165 |
Corporate Officer/Principal | 89 |
Chairman | 67 |
Chief Executive Officer | 40 |
Independent Dir/Board Member | 28 |
Most connected contacts
- Stock Market
- Insiders
- Martin Møller
- Company connections